Log in to search using one of your social media accounts:

 

Oxybutynin Frequently Prescribed in OAB (CME/CE)
(MedPage Today) -- Antimuscarinic with cognitive side effects often given to older patients with bladder symptoms (Source: MedPage Today OB/GYN)
Source: MedPage Today OB/GYN - May 15, 2017 Category: OBGYN Source Type: news

Oxybutynin Use'Alarmingly High' in Older Patients Oxybutynin Use'Alarmingly High' in Older Patients
Despite well-documented links between antimuscarinic agents and dementia in the elderly, inappropriate prescribing continues, and might be driven by restrictive formularies and a lack of awareness.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 28, 2017 Category: Consumer Health News Tags: Urology News Source Type: news

Concern over high US prescribing levels of common drug linked to dementia
A new analysis raises concern over high prescription rates in the USA of a common drug used to treat overactive bladder. The drug, oxybutynin, when taken orally, is consistently linked with cognitive impairment and dementia in the elderly. The analysis shows that oxybutynin, is prescribed in more than a quarter of cases of overactive bladder (27.3%), even though other more suitable drugs are available. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - March 27, 2017 Category: Science Source Type: news

Bladder drug taken by thousands is linked to dementia
A drug marketed by the NHS as a primary medication for urinary incontinence has been linked to dementia. Doctors warned that oxybutynin should no longer be used at all. (Source: the Mail online | Health)
Source: the Mail online | Health - March 27, 2017 Category: Consumer Health News Source Type: news

Controversies, Advances in Urology in Conference Limelight Controversies, Advances in Urology in Conference Limelight
The search for better prostate cancer biomarkers and questions about drugs, such as oxybutynin and PDE5 inhibitors, are among the thorny topics that will be tackled at the European urology congress. (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 20, 2017 Category: Consumer Health News Tags: Urology News Source Type: news

Anturol (Oxybutynin) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - January 24, 2017 Category: Drugs & Pharmacology Source Type: news

Gelnique (Oxybutynin Chloride 10 % Gel) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - January 24, 2017 Category: Drugs & Pharmacology Source Type: news

Ditropan XL (Oxybutynin Chloride Extended Release Tablets) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - September 12, 2016 Category: Drugs & Pharmacology Source Type: news

Juniper Pharmaceuticals Affirms Development Pathway for Oxybutynin Intra-vaginal Ring for Overactive Bladder in Women
JNP-0101 on Track for 2016 Investigational New Drug ("IND") Filing BOSTON, March 21, 2016 -- (Healthcare Sales & Marketing Network) -- Juniper Pharmaceuticals, Inc. (JNP) ("Juniper" or the "Company"), a women's health ther... Biopharmaceuticals, Urology, Drug Delivery, FDAJuniper Pharmaceuticals, oxybutynin, intra-vaginal, overactive bladder (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 21, 2016 Category: Pharmaceuticals Source Type: news

A Troubling Potential Link Between Sleep Aids And Mental Illness
In today's "always on," high-stress world, it has become commonplace to turn to over-the-counter sleep aids for a little help with drifting off into dreamland at night. However, that habit, if made a consistent one, could lead to potentially serious damage when it comes to ones mental health. A new study zeroing in on anticholinergic drugs -- a category that includes common non-prescription sleeping aids and antihistamines like Benadryl -- found that the long-term use of such medications in higher doses can lead to an increased risk of developing dementia, including Alzheimer's disease, in the future. It's the f...
Source: Science - The Huffington Post - April 7, 2015 Category: Science Source Type: news

oxybutynin, Ditropan (discontinued brand in the US); Ditropan XL; Oxytrol; Anturol; Gelnique
Title: oxybutynin, Ditropan (discontinued brand in the US); Ditropan XL; Oxytrol; Anturol; GelniqueCategory: MedicationsCreated: 11/28/2004 12:49:00 PMLast Editorial Review: 7/10/2014 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - July 10, 2014 Category: Drugs & Pharmacology Source Type: news

Oxytrol (oxybutynin) for the Treatment of Overactive Bladder (OAB) in Women
Oxytrol (oxybutynin) is a transdermal patch indicated for the treatment of overactive bladder in women who have symptoms of urge urinary incontinence, urgency and frequency. (Source: Drug Development Technology)
Source: Drug Development Technology - May 1, 2013 Category: Pharmaceuticals Source Type: news

FDA OK’s First OTC Remedy For Overactive Bladder
WebMD Medical News By Kathleen Doheny Reviewed by Laura J. Martin, MD Jan. 25, 2013 — The FDA has approved Oxytrol for Women, the first over-the-counter treatment for overactive bladder in women 18 and older. The condition affects more than 20 million American women, according to Merck, the drug’s manufacturer. It will still only be available in prescription form for men. Oxytrol helps relax the overactive bladder muscle that leads to symptoms such as the sudden need to urinate and leaking of urine. Oxytrol for Women is in the form of a patch, applied to the skin every four days, Merck says. It is expected to ...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - January 30, 2013 Category: Consumer Health News Authors: mreal197 Tags: WebMD News Source Type: news

Oxytrol Approved By FDA For Overactive Bladder In Women
The first over-the-counter medication for overactive bladder was given approval by the U.S. Food and Drug Administration for use by women, but still remains available just by prescription for men. Oxytrol consists of a medicine called oxybutynin (a anticholinergic) that functions by easing the bladder muscle. It comes in the form of a patch that a person replaces on the skin every four days. The patch emits 3.9 milligrams of oxybutynin per day. Shaw Chen, M.D., Ph.D... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - January 26, 2013 Category: Consumer Health News Tags: Urology / Nephrology Source Type: news

Oxytrol For Overactive Bladder In Women Approved By FDA
Oxytrol (Oxybutynin Transdermal System) the first over-the-counter medication for overactive bladder was given approval by the U.S. Food and Drug Administration for use by women, but still remains available just by prescription for men. Oxytrol consists of a medicine called oxybutynin (a anticholinergic) that functions by easing the bladder muscle. It comes in the form of a patch that a person replaces on the skin every four days. The patch emits 3.9 milligrams of oxybutynin per day. Shaw Chen, M.D., Ph.D... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - January 26, 2013 Category: Consumer Health News Tags: Urology / Nephrology Source Type: news

Bladder Control Drug Gets FDA OTC Go-Ahead
(MedPage Today) -- SILVER SPRING, Md. -- A patch containing oxybutynin (Oxytrol) for controlling overactive bladder may be sold over-the-counter for women 18 and older, the FDA said Friday. (Source: MedPage Today OB/GYN)
Source: MedPage Today OB/GYN - January 25, 2013 Category: OBGYN Source Type: news

FDA Approves OXYTROL(R) FOR WOMEN, the First Over-the-Counter Treatment for Overactive Bladder in Women
New Over-the-Counter Option for More Than 20 Million Women with Overactive Bladder WHITEHOUSE STATION, N.J., Jan. 25, 2013 (HSMN NewsFeed) -- Merck (MRK), known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug A... Biopharmaceuticals, Drug Delivery, Urology, FDAMerck, OXYTROL FOR WOMEN, oxybutynin transdermal, overactive bladder (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 25, 2013 Category: Pharmaceuticals Source Type: news

Prevalence of anticholinergic use among older home health patients
Source: Journal of Clinical Nursing Area: Evidence> Medicines Management> References Anticholinergic usage patterns for patients in the USA aged 65 years and older who received home health (HH) services were examined using the 2007 National Home and Hospice Care Survey (NHHCS) data. Slightly over 80% (80.30; 95% CI, 77.5 to 83.25) of older HH patients received at least one anticholinergic drug. High prevalence of the use of higher level anticholinergics was found.  Almost 30% (29.62; 95% CI, 26.90 to 32.33) took either a level 2 (5.42%; 95% CI, 4.00 to 6.85) or level 3 (25.99%; 95% CI, 23.54 to 28.44) dr...
Source: NeLM - Care of Older People - January 9, 2013 Category: Geriatrics Source Type: news